{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:41:41Z","timestamp":1792453301738,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korea Institute of Drug Safety and Risk Management","award":["2023"],"award-info":[{"award-number":["2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08279-6","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:40:32Z","timestamp":1751420432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk of Alzheimer\u2019s disease and Parkinson\u2019s disease following androgen deprivation therapy in a real world nationwide cohort"],"prefix":"10.1038","volume":"15","author":[{"given":"Ha-Lim","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjung","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-hwan","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwoo","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2200-5019","authenticated-orcid":false,"given":"Chang Wook","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7780-159X","authenticated-orcid":false,"given":"Hankil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"8279_CR1","unstructured":"Cancer IAfRo. Cancer Today; Data visualization tools for exploring the global cancer burden in 2020, (2024)."},{"key":"8279_CR2","doi-asserted-by":"publisher","unstructured":"Kang, M. J. et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2020. crt 55(2), 385\u2013399. https:\/\/doi.org\/10.4143\/crt.2023.447 (2023).","DOI":"10.4143\/crt.2023.447"},{"issue":"1","key":"8279_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L. et al. Cancer statistics, 2023. CA Cancer J. Clin. 73(1), 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl 1","key":"8279_CR4","first-page":"S3","volume":"9","author":"MA Perlmutter","year":"2007","unstructured":"Perlmutter, M. A. & Lepor, H. Androgen deprivation therapy in the treatment of advanced prostate cancer. Rev. Urol. 9(Suppl 1), S3\u20138 (2007).","journal-title":"Rev. Urol."},{"issue":"3","key":"8279_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endrev\/bnab002","volume":"42","author":"K Desai","year":"2021","unstructured":"Desai, K., McManus, J. M. & Sharifi, N. Hormonal therapy for prostate cancer. Endocr. Rev. 42(3), 354\u2013373. https:\/\/doi.org\/10.1210\/endrev\/bnab002 (2021).","journal-title":"Endocr. Rev."},{"issue":"6","key":"8279_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.urolonc.2009.09.004","volume":"29","author":"SM Gilbert","year":"2011","unstructured":"Gilbert, S. M., Kuo, Y. F. & Shahinian, V. B. Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States. Urol. Oncol. 29(6), 647\u2013653. https:\/\/doi.org\/10.1016\/j.urolonc.2009.09.004 (2011).","journal-title":"Urol. Oncol."},{"issue":"5","key":"8279_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","volume":"67","author":"PL Nguyen","year":"2015","unstructured":"Nguyen, P. L. et al. Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur. Urol. 67(5), 825\u2013836. https:\/\/doi.org\/10.1016\/j.eururo.2014.07.010 (2015).","journal-title":"Eur. Urol."},{"issue":"1","key":"8279_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/jnc.13371","volume":"136","author":"SW Son","year":"2016","unstructured":"Son, S. W. et al. Testosterone depletion increases the susceptibility of brain tissue to oxidative damage in a restraint stress mouse model. J. Neurochem. 136(1), 106\u2013117. https:\/\/doi.org\/10.1111\/jnc.13371 (2016).","journal-title":"J. Neurochem"},{"key":"8279_CR9","doi-asserted-by":"publisher","unstructured":"Bianchi, V. E. et al. Androgen therapy in neurodegenerative diseases. J. Endocr. Soc. 4(11). https:\/\/doi.org\/10.1210\/jendso\/bvaa120 (2020).","DOI":"10.1210\/jendso\/bvaa120"},{"issue":"3","key":"8279_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.5534\/wjmh.210019","volume":"40","author":"JW Kim","year":"2022","unstructured":"Kim, J. W. et al. Androgen deprivation therapy in patients with prostate cancer is associated with the risk of subsequent alzheimer\u2019s disease but not with vascular dementia. World J. Mens Health. 40(3), 481\u2013489. https:\/\/doi.org\/10.5534\/wjmh.210019 (2022).","journal-title":"World J. Mens Health"},{"key":"8279_CR11","doi-asserted-by":"publisher","unstructured":"Liu, J. M. et al. Association between androgen deprivation therapy and risk of dementia in men with prostate Cancer. Cancers (Basel). 13(15). https:\/\/doi.org\/10.3390\/cancers13153861 (2021).","DOI":"10.3390\/cancers13153861"},{"issue":"4","key":"8279_CR12","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/ju.0000000000002335","volume":"207","author":"PE Lonergan","year":"2022","unstructured":"Lonergan, P. E. et al. Androgen deprivation therapy and the risk of dementia after treatment for prostate cancer. J. Urol. 207(4), 832\u2013840. https:\/\/doi.org\/10.1097\/ju.0000000000002335 (2022).","journal-title":"J. Urol."},{"issue":"1","key":"8279_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s42444-019-0005-0","volume":"20","author":"J Park","year":"2019","unstructured":"Park, J. et al. Validation of diagnostic codes of major clinical outcomes in a National health insurance database. Int. J. Arrhythmia. 20(1), 5. https:\/\/doi.org\/10.1186\/s42444-019-0005-0 (2019).","journal-title":"Int. J. Arrhythmia"},{"issue":"12","key":"8279_CR14","doi-asserted-by":"publisher","first-page":"e0244660","DOI":"10.1371\/journal.pone.0244660","volume":"15","author":"M Shim","year":"2020","unstructured":"Shim, M. et al. Risk of dementia and parkinson\u2019s disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study. PLoS One. 15(12), e0244660. https:\/\/doi.org\/10.1371\/journal.pone.0244660 (2020).","journal-title":"PLoS One"},{"issue":"2","key":"8279_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4143\/crt.2018.119","volume":"51","author":"BS Tae","year":"2019","unstructured":"Tae, B. S. et al. Correlation of androgen deprivation therapy with cognitive dysfunction in patients with prostate cancer: A nationwide population-based study using the National health insurance service database. Cancer Res. Treat. 51(2), 593\u2013602. https:\/\/doi.org\/10.4143\/crt.2018.119 (2019).","journal-title":"Cancer Res. Treat."},{"issue":"2","key":"8279_CR16","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4143\/crt.2021.044","volume":"54","author":"MS Yang","year":"2022","unstructured":"Yang, M. S. et al. Validation of cancer diagnosis based on the National health insurance service database versus the National Cancer registry database in Korea. Cancer Res. Treat. 54(2), 352\u2013361. https:\/\/doi.org\/10.4143\/crt.2021.044 (2022).","journal-title":"Cancer Res. Treat."},{"issue":"3","key":"8279_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/pds.1357","volume":"16","author":"S Suissa","year":"2007","unstructured":"Suissa, S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf. 16(3), 241\u2013249. https:\/\/doi.org\/10.1002\/pds.1357 (2007).","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"9","key":"8279_CR18","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1161\/strokeaha.112.655803","volume":"43","author":"RN Kalaria","year":"2012","unstructured":"Kalaria, R. N. Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans. Stroke 43(9), 2526\u20132534. https:\/\/doi.org\/10.1161\/strokeaha.112.655803 (2012).","journal-title":"Stroke"},{"issue":"1","key":"8279_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s10194-022-01484-y","volume":"23","author":"K Hurh","year":"2022","unstructured":"Hurh, K. et al. Increased risk of all-cause, Alzheimer\u2019s, and vascular dementia in adults with migraine in Korea: a population-based cohort study. J. Headache Pain. 23(1), 108. https:\/\/doi.org\/10.1186\/s10194-022-01484-y (2022).","journal-title":"J. Headache Pain"},{"issue":"6","key":"8279_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3988\/jcn.2022.18.6.711","volume":"18","author":"HS Kwon","year":"2022","unstructured":"Kwon, H. S. et al. Comparing the characteristics of patients with newly diagnosed dementia before and after 2008 in Seoul, South Korea: A population-based study. J. Clin. Neurol. (Seoul Korea). 18(6), 711\u2013713. https:\/\/doi.org\/10.3988\/jcn.2022.18.6.711 (2022).","journal-title":"J. Clin. Neurol. (Seoul Korea)"},{"issue":"2","key":"8279_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin, P. C. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm. Stat. 10(2), 150\u2013161. https:\/\/doi.org\/10.1002\/pst.433 (2011).","journal-title":"Pharm. Stat."},{"issue":"8","key":"8279_CR22","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","volume":"179","author":"CAC Coupland","year":"2019","unstructured":"Coupland, C. A. C. et al. Anticholinergic drug exposure and the risk of dementia: A nested case-control study. JAMA Intern. Med. 179(8), 1084\u20131093. https:\/\/doi.org\/10.1001\/jamainternmed.2019.0677 (2019).","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"8279_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12916-025-03851-3","volume":"23","author":"M Mo","year":"2025","unstructured":"Mo, M. et al. Antidepressant use and cognitive decline in patients with dementia: a national cohort study. BMC Med. 23(1), 82. https:\/\/doi.org\/10.1186\/s12916-025-03851-3 (2025).","journal-title":"BMC Med."},{"issue":"2","key":"8279_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1200\/JCO.2016.69.6203","volume":"35","author":"F Khosrow-Khavar","year":"2017","unstructured":"Khosrow-Khavar, F. et al. Androgen deprivation therapy and the risk of dementia in patients with prostate cancer. J. Clin. Oncol. 35(2), 201\u2013207 (2017).","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"8279_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41391-019-0189-3","volume":"23","author":"A Krasnova","year":"2020","unstructured":"Krasnova, A. et al. Risk of dementia following androgen deprivation therapy for treatment of prostate cancer. Prostate Cancer Prostatic Dis. 23(3), 410\u2013418 (2020).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"8279_CR26","doi-asserted-by":"crossref","unstructured":"Hinojosa-Gonzalez, D. E. et al. Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 1\u201313 (2024).","DOI":"10.21203\/rs.3.rs-3221041\/v1"},{"issue":"3","key":"8279_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/andr.12187","volume":"4","author":"S Chung","year":"2016","unstructured":"Chung, S. et al. Androgen deprivation therapy did not increase the risk of Alzheimer\u2019s and Parkinson\u2019s disease in patients with prostate cancer. Andrology 4(3), 481\u2013485 (2016).","journal-title":"Andrology"},{"key":"8279_CR28","doi-asserted-by":"publisher","first-page":"101657","DOI":"10.1016\/j.canep.2019.101657","volume":"64","author":"J-H Hong","year":"2020","unstructured":"Hong, J-H. et al. Different androgen deprivation therapies might have a differential impact on cognition-An analysis from a population-based study using time-dependent exposure model. Cancer Epidemiol. 64, 101657 (2020).","journal-title":"Cancer Epidemiol."},{"issue":"3","key":"8279_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41391-018-0036-y","volume":"21","author":"HS Ng","year":"2018","unstructured":"Ng, H. S. et al. Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study. Prostate Cancer Prostatic Dis. 21(3), 403\u2013410 (2018).","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"1","key":"8279_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/bju.14666","volume":"124","author":"D Robinson","year":"2019","unstructured":"Robinson, D. et al. Androgen deprivation therapy for prostate cancer and risk of dementia. BJU Int. 124(1), 87\u201392 (2019).","journal-title":"BJU Int."},{"issue":"11","key":"8279_CR31","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1001\/jamaoncol.2018.4423","volume":"4","author":"R Deka","year":"2018","unstructured":"Deka, R. et al. Association of androgen deprivation therapy with dementia in men with prostate cancer who receive definitive radiation therapy. JAMA Oncol. 4(11), 1616\u20131617 (2018).","journal-title":"JAMA Oncol."},{"issue":"4","key":"8279_CR32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.4103\/1673-5374.245477","volume":"14","author":"XS Yan","year":"2019","unstructured":"Yan, X. S. et al. Protective mechanism of testosterone on cognitive impairment in a rat model of Alzheimer\u2019s disease. Neural Regen Res. 14(4), 649\u2013657. https:\/\/doi.org\/10.4103\/1673-5374.245477 (2019).","journal-title":"Neural Regen Res."},{"issue":"10","key":"8279_CR33","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3349\/ymj.2021.62.10.948","volume":"62","author":"YJ Choi","year":"2021","unstructured":"Choi, Y. J. et al. Prevalence of dementia in Korea based on hospital utilization data from 2008 to 2016. Yonsei Med. J. 62(10), 948\u2013953. https:\/\/doi.org\/10.3349\/ymj.2021.62.10.948 (2021).","journal-title":"Yonsei Med. J."},{"issue":"3","key":"8279_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000160960","volume":"26","author":"JH Jhoo","year":"2008","unstructured":"Jhoo, J. H. et al. Prevalence of dementia and its subtypes in an elderly urban Korean population: results from the Korean longitudinal study on health and aging (KLoSHA). Dement. Geriatr. Cogn. Disord. 26(3), 270\u2013276. https:\/\/doi.org\/10.1159\/000160960 (2008).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"2","key":"8279_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jalz.2017.07.755","volume":"14","author":"MR Azarpazhooh","year":"2018","unstructured":"Azarpazhooh, M. R. et al. Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc. 14(2), 148\u2013156. https:\/\/doi.org\/10.1016\/j.jalz.2017.07.755 (2018).","journal-title":"Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc."},{"issue":"6","key":"8279_CR36","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1097\/ju.0000000000002121","volume":"206","author":"CJ Ryan","year":"2021","unstructured":"Ryan, C. J. et al. Management of patients with metastatic castration-sensitive prostate cancer in the real-world setting in the United States. J. Urol. 206(6), 1420\u20131429. https:\/\/doi.org\/10.1097\/ju.0000000000002121 (2021).","journal-title":"J. Urol."},{"key":"8279_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.urology.2023.08.021","volume":"182","author":"AE Braun","year":"2023","unstructured":"Braun, A. E. et al. Association between common urologic medications and onset of alzheimer\u2019s disease and related dementias in men with prostate cancer managed by different primary treatment modalities. Urology 182, 161\u2013167 (2023).","journal-title":"Urology"},{"issue":"4","key":"8279_CR38","first-page":"181","volume":"16","author":"K Hoyland","year":"2014","unstructured":"Hoyland, K. et al. Post-radical prostatectomy incontinence: etiology and prevention. Rev. Urol. 16(4), 181\u2013188 (2014).","journal-title":"Rev. Urol."},{"issue":"5","key":"8279_CR39","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3349\/ymj.2016.57.5.1145","volume":"57","author":"JK Jo","year":"2016","unstructured":"Jo, J. K. et al. Urinary continence after robot-assisted laparoscopic radical prostatectomy: the impact of intravesical prostatic protrusion. Yonsei Med. J. 57(5), 1145\u20131151. https:\/\/doi.org\/10.3349\/ymj.2016.57.5.1145 (2016).","journal-title":"Yonsei Med. J."},{"issue":"1","key":"8279_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12874-017-0405-6","volume":"17","author":"IS Cho","year":"2017","unstructured":"Cho, I. S. et al. Statistical methods for elimination of guarantee-time bias in cohort studies: a simulation study. BMC Med. Res. Methodol. 17(1), 126. https:\/\/doi.org\/10.1186\/s12874-017-0405-6 (2017).","journal-title":"BMC Med. Res. Methodol."},{"issue":"4","key":"8279_CR41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tips.2008.12.006","volume":"30","author":"RD Brinton","year":"2009","unstructured":"Brinton, R. D. Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends Pharmacol. Sci. 30(4), 212\u2013222. https:\/\/doi.org\/10.1016\/j.tips.2008.12.006 (2009).","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"8279_CR42","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3109\/13697137.2012.660613","volume":"15","author":"PM Maki","year":"2012","unstructured":"Maki, P. M. & Henderson, V. W. Hormone therapy, dementia, and cognition: the women\u2019s health initiative 10 years on. Climacteric: J. Int. Menopause Soc. 15(3), 256\u2013262. https:\/\/doi.org\/10.3109\/13697137.2012.660613 (2012).","journal-title":"Climacteric: J. Int. Menopause Soc."},{"issue":"4","key":"8279_CR43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.neurobiolaging.2009.04.008","volume":"32","author":"ER Rosario","year":"2011","unstructured":"Rosario, E. R. et al. Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer\u2019s disease. Neurobiol. Aging. 32(4), 604\u2013613. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.04.008 (2011).","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"8279_CR44","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1200\/jco.2015.63.6266","volume":"34","author":"KT Nead","year":"2016","unstructured":"Nead, K. T. et al. Androgen deprivation therapy and future Alzheimer\u2019s disease risk. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 34(6), 566\u2013571. https:\/\/doi.org\/10.1200\/jco.2015.63.6266 (2016).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08279-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08279-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08279-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:40:35Z","timestamp":1751420435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08279-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8279"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08279-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Ajou University (202305-HB-EX-001), which waived the requirement for informed consent as only de-identified data were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23490"}}